cmpabon Profile Banner
Cindy M. Pabon, MD Profile
Cindy M. Pabon, MD

@cmpabon

Followers
938
Following
6K
Statuses
592

Assistant Prof GI Med Onc @SylvesterCancer focused on Gastroesophageal Ca | Trained @MDAndersonNews @IMResidencyDuke & @UFMedicine | Wife & mom | Go gators! 🐊

Miami, FL
Joined January 2020
Don't wanna be here? Send us removal request.
@cmpabon
Cindy M. Pabon, MD
@cmpabon
5 years
In 2018 I shared a message on advocacy as physicians. As the depth of #StructuralRacism in our country is further revealed by the devastating loss of #GeorgeFloyd and disparities within #COVID19, I challenge you to stand up for your community #MedTwitter
3
8
64
@cmpabon
Cindy M. Pabon, MD
@cmpabon
2 days
@Lymphoma_Doc @ASCO Congrats, go 🐊!
0
0
1
@cmpabon
Cindy M. Pabon, MD
@cmpabon
4 days
Should I Get Tested for H. Pylori? #Hpylori #STCSM #ESOCSM @SylvesterCancer
0
0
1
@cmpabon
Cindy M. Pabon, MD
@cmpabon
9 days
@BernabeCarolina @gonzalosancheze 🥳💜
0
0
0
@cmpabon
Cindy M. Pabon, MD
@cmpabon
12 days
@BernabeCarolina 🥰🥰🥰
0
0
1
@cmpabon
Cindy M. Pabon, MD
@cmpabon
12 days
RT @MichaelLaPelusa: Always great to learn new data in SF and connect with mentors + friends @ASCO GI. Thanks to @ConquerCancerFd for the M…
0
13
0
@cmpabon
Cindy M. Pabon, MD
@cmpabon
14 days
RT @GIMedOnc: #GI25 BREAKWATER @skopetz changing the paradigm yet again! The true master of BRAF and colorectal targeted therapy. BRAF…
0
4
0
@cmpabon
Cindy M. Pabon, MD
@cmpabon
15 days
RT @KrishanJethwa: 🔥NRG GI-007🔥 LA-Esophagus Carcinoma 🔍 dCRT (50.4 Gy/28 fx carbo/taxol) + endoscopically injected oncolytic virus OBP-3…
0
47
0
@cmpabon
Cindy M. Pabon, MD
@cmpabon
15 days
RT @KellyMezaMD: #ASCOGI2025 Presenting our poster on #biomarkers of response to FGFR inhibitors on patients with #cholangiocarcinoma @MDAn…
0
4
0
@cmpabon
Cindy M. Pabon, MD
@cmpabon
15 days
@KellyMezaMD @MDAndersonNews @JavleMilind @marklewismd @mcruzcorrea @BernabeCarolina @ShrutiPatelMD Woooo!!! Get it Dr. Meza! 👏 👏 👏
0
0
2
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
@rachnatshroff @drjunaidarsh @UAZCancer @ajscott40 @ASCO This was such a great session!! So many useful tips I didn’t know I needed until embarking on year 1 as an attending 🙏
0
0
3
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Anna Dorothea Wagner presents EORTC-1203 GITC "INNOVATION": Integration of trastuzumab +/- pertuzumab into perioperative chemo in HER2+ GC. Adding HER-2 agents improves mpRR but didn't result in OS benefit when amended to group with SOC FLOT. Tx with noted toxicities.
Tweet media one
Tweet media two
Tweet media three
0
0
1
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Xuefeng Leng presents neoadjuvant chemoRT +/- sintilimab for ESCC. Statistically significant improvement in pCR rates...but is this similar to the reduction in disease we see with CHECKMATE-577? Will need long term survival data for both studies to see if sequence matters.
Tweet media one
Tweet media two
0
0
4
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Maheswari Senthil's excellent review on peritoneal disease in GC, the role of peritoneal-directed therapies, and the takeaways from DRAGON-01 & PRECISE-SG1.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
3
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Evelyn Yi Ting Wong presents PRECISE-SG1: HIPEC/CRS in patients with met GC (peritoneal-limited dz) who achieved PCI<7 from systemic tx. 👉Cytology negative rate increased from 35 to 86% 👉mOS 17.5m
Tweet media one
Tweet media two
0
0
2
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Chao Yan presents Ph3 DRAGON-01 trial: neoadjuvant IP & IV paclitaxel plus S-1 significantly improved OS compared to IV paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis, with manageable toxicity and greater likelihood of converting to surgery.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
3
5
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Thank you, Dr. Pamela Kunz for an exceptional keynote and reminder that no matter the political environment, our advocacy for our patients and for each other goes on 👏
Tweet media one
Tweet media two
Tweet media three
0
0
5
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Naomi Kakushima notes that H pylori testing + endoscopic screening can reduce GC mortality. EGD should include enhanced imaging technology, sufficient photos taken & close attn to often overlooked sites. ER is a viable option for select patients w/ EGC w/ great 5-year OS.
Tweet media one
0
3
6
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Travis Grotz proposes TNT approach as an opportunity to ensure adequate tx received in locally adv G/GEJ cancer before curative resection. QOL post-op is harsh and not ideal for intensive adjv chemo. Additionally, studies have shown that >5 cycles improve OS. Thoughts?
Tweet media one
Tweet media two
0
2
9
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
#GI25 Lakshmi Balasubramanian presents advancements in treatment of gastric cancers 👉Biomarker testing is essential 👉MDC often needed 👉We need to address gaps in patient access to oncologic care, practice-changing drugs, and novel drug delivery systems (i.e. HIPEC)
Tweet media one
0
2
7
@cmpabon
Cindy M. Pabon, MD
@cmpabon
16 days
No better way to kick off the first upper GI session of #GI25 than with my phenomenal mentor as chair! Professor & Doctora Mariela Blum Murphy 👏👏👏
Tweet media one
0
0
10